Chesnara Plc: Fourth acquisition in two years
12 November 2026
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is making waves in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $747.86 million, this U.S.-based..
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a prominent player in the biotechnology sector, has been on investors’ radar due to its significant potential upside of 58.65%,..
Arvinas, Inc. (NASDAQ: ARVN) stands at the forefront of biotechnology innovation, leveraging its pioneering PROTAC (Proteolysis Targeting Chimeras) technology to address some of the most challenging..
AbCellera Biologics Inc. (NASDAQ: ABCL) is capturing investor attention with its impressive potential upside of over 100%, as analysts set an average price target of $9.29...
In the ever-evolving landscape of healthcare, Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands as a pivotal player, offering vital talent management services across the United States...
Emergent BioSolutions Inc. (NYSE: EBS), a specialized player in the healthcare sector, particularly within the drug manufacturing industry, has recently caught the attention of investors with..
COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering biotechnology company, is making significant strides in the field of mental health treatment. Headquartered in London, the company is..
Tectonic Therapeutic, Inc. (NASDAQ: TECX) is capturing the attention of investors with a striking potential upside of 225.76%, according to analyst ratings. This biotechnology firm, headquartered..
iRadimed Corporation (NASDAQ: IRMD), a leading player in the healthcare sector, specializes in the niche market of MRI-compatible medical devices. With a market capitalization of $892.31..
Navigating the complex landscape of healthcare investment requires keen insight into companies like InnovAge Holding Corp. (NASDAQ: INNV), which stands out with its significant 41.64% potential..
Prothena Corporation plc (NASDAQ: PRTA), an innovative player in the biotechnology sector, is generating buzz among investors with its promising pipeline and strong upside potential. Despite..
For investors with an eye toward the biotechnology sector, PureTech Health plc (NASDAQ: PRTC) presents a fascinating opportunity. As a company dedicated to developing innovative biotechnological..
Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company based in San Diego, California, is attracting significant attention in the biotech sector with its promising developments..
Cogent Biosciences, Inc. (NASDAQ: COGT) stands out in the biotechnology sector with its precision therapies targeting genetically defined diseases. As a company focused on innovative treatments,..
Anavex Life Sciences Corp. (NASDAQ: AVXL) stands at the forefront of the biotechnology sector, particularly in the realm of neurodegenerative and neuropsychiatric disorders. This New York-based..
Organogenesis Holdings Inc. (NASDAQ: ORGO) stands at a fascinating intersection of regenerative medicine and financial scrutiny. This U.S.-based company, specializing in advanced wound care and surgical..
Enliven Therapeutics, Inc. (NASDAQ: ELVN) is emerging as a compelling opportunity for investors seeking exposure in the biotechnology sector. With a market capitalization of $1.17 billion,..
Investors seeking opportunities in the healthcare sector should turn their attention to Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a promising player in the biotechnology industry, headquartered in..
Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical innovator, is capturing investor attention with a potential upside of 87.27%. Specializing in precision medicines for complex conditions..
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company that has garnered significant attention in the healthcare sector. With a market capitalization of $355.68 million,..
